Breast cancer: from "maximum tolerable" to "minimum effective" treatment
- PMID: 23061042
- PMCID: PMC3465814
- DOI: 10.3389/fonc.2012.00125
Breast cancer: from "maximum tolerable" to "minimum effective" treatment
Abstract
Randomized trials have played a fundamental role in identifying better treatments for most type of diseases, especially in the oncological field. In breast cancer, the shift from "maximum tolerable" to "minimum effective" treatment has been evident since the 1970s and has been based on the results of international randomized trials. The progress of breast surgery represents an excellent model of the evolution of science and the aim of this article is to review the main randomized studies that changed everyday practice in breast surgery.
Keywords: breast cancer; conservative treatment; maximum tolerable treatment; minimum effective treatment; randomized trials.
References
-
- Arriagada R., Lê M. G., Rochard F., Contesso G. (1996). Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J. Clin. Oncol. 14, 1558–1564 - PubMed
-
- Blichert-Toft M., Rose C., Andersen J. A., Overgaard M., Axelsson C. K., Andersen K. W., Mouridsen H. T. (1992). Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J. Natl. Cancer Inst. Monogr. 19–25. PMID:1627427. - PubMed
-
- Fisher B., Anderson S., Bryant J., Margolese R. G., Deutsch M., Fisher E. R., Jeong J. H., Wolmark N. (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 347, 1233–1241 10.1056/NEJMoa022152 - DOI - PubMed